These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23264301)

  • 1. Comment on: Zhang et al. Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies. Diabetes Care 2012;35:1388-1393.
    Lapice E; Cocozza S; Riccardi G; Vaccaro O
    Diabetes Care; 2013 Jan; 36(1):e18. PubMed ID: 23264301
    [No Abstract]   [Full Text] [Related]  

  • 2. Peroxisome proliferator-activated receptor γ polymorphism Pro12Ala Is associated with nephropathy in type 2 diabetes: evidence from meta-analysis of 18 studies.
    Zhang H; Zhu S; Chen J; Tang Y; Hu H; Mohan V; Venkatesan R; Wang J; Chen H
    Diabetes Care; 2012 Jun; 35(6):1388-93. PubMed ID: 22619290
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Pro12Ala polymorphism and albuminuria in type 2 diabetic nephropathy.
    Chen YN; Wang PW; Tung SC; Kuo MC; Weng SW; Chou CK; Chang CM; Tsa CJ; Taso CF; Shen FC; Chen JF
    J Diabetes Investig; 2020 Jul; 11(4):923-929. PubMed ID: 31912623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peroxisome proliferator activated receptor γ2 gene Pro12Ala gene polymorphism in type 2 diabetes and its relationship with diabetic nephropathy.
    Azab MM; Abdel-Azeez HA; Zanaty MF; El Alawi SM
    Clin Lab; 2014; 60(5):743-9. PubMed ID: 24839816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of peroxisome proliferator-activated receptor γ Pro12Ala gene polymorphism with type 2 diabetic nephropathy risk in Caucasian population.
    Zhou TB; Guo XF; Yin SS
    J Recept Signal Transduct Res; 2014 Jun; 34(3):180-4. PubMed ID: 24329532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients: comment on the study by Liu et al.
    Lapice E; Pinelli M; Riccardi G; Vaccaro O
    Diabetes Care; 2010 Aug; 33(8):e114; author reply e115. PubMed ID: 20668149
    [No Abstract]   [Full Text] [Related]  

  • 7. The relationship of the peroxisome proliferator-activated receptor-gamma 2 exon 2 and exon 6 gene polymorphism in Turkish type 2 diabetic patients with and without nephropathy.
    Erdogan M; Karadeniz M; Eroglu Z; Tezcanli B; Selvi N; Yilmaz C
    Diabetes Res Clin Pract; 2007 Dec; 78(3):355-9. PubMed ID: 17681394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPARgamma-2) gene is associated with greater insulin sensitivity and decreased risk of type 2 diabetes in an Iranian population.
    Meshkani R; Taghikhani M; Larijani B; Bahrami Y; Khatami S; Khoshbin E; Ghaemi A; Sadeghi S; Mirkhani F; Molapour A; Adeli K
    Clin Chem Lab Med; 2007; 45(4):477-82. PubMed ID: 17439324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Pro12Ala polymorphism of the peroxisome proliferator-activated receptor gamma and immunological processes in patients with type 2 diabetes and insulin resistance].
    Gacka M; Bednarska-Chabowska D; Dobosz T; Szymaniec S; Jakobsche U; Lebioda A; Adamiec R
    Przegl Lek; 2007; 64(6):393-7. PubMed ID: 18159845
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between PPARγ Pro12Ala gene polymorphism and type 2 diabetic nephropathy risk in Asian population: results from a meta-analysis.
    Liu G; Zhou TB; Jiang Z; Zheng D; Yuan F; Li Y; Hu H; Chen Z
    J Recept Signal Transduct Res; 2014 Apr; 34(2):131-6. PubMed ID: 24303936
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro12Ala polymorphism in the PPARG gene contributes to the development of diabetic nephropathy in Chinese type 2 diabetic patients.
    Liu L; Zheng T; Wang F; Wang N; Song Y; Li M; Li L; Jiang J; Zhao W
    Diabetes Care; 2010 Jan; 33(1):144-9. PubMed ID: 19837787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Peroxisome proliferator-activated receptor gamma polymorphism Pro12Ala is associated with nephropathy in type 2 diabetes.
    Pollex RL; Mamakeesick M; Zinman B; Harris SB; Hegele RA; Hanley AJ
    J Diabetes Complications; 2007; 21(3):166-71. PubMed ID: 17493550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The association between the PPARγ2 Pro12Ala polymorphism and nephropathy susceptibility in type 2 diabetes: a meta-analysis based on 9,176 subjects.
    Wang L; Teng Z; Cai S; Wang D; Zhao X; Yu K
    Diagn Pathol; 2013 Jul; 8():118. PubMed ID: 23856170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PPARγ2 Pro12Ala variant is protective against progression of nephropathy in people with type 2 diabetes.
    Lapice E; Monticelli A; Cocozza S; Pinelli M; Cocozza S; Bruzzese D; Riccardi G; Vaccaro O
    J Transl Med; 2015 Mar; 13():85. PubMed ID: 25889595
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus.
    Tavares V; Hirata RD; Rodrigues AC; Monte O; Salles JE; Scalissi N; Speranza AC; Hirata MH
    Diabetes Obes Metab; 2005 Sep; 7(5):605-11. PubMed ID: 16050954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferator-activated receptor gamma Pro12Ala interacts with the insulin receptor substrate 1 Gly972Arg and increase the risk of insulin resistance and diabetes in the mixed ancestry population from South Africa.
    Vergotine Z; Yako YY; Kengne AP; Erasmus RT; Matsha TE
    BMC Genet; 2014 Jan; 15():10. PubMed ID: 24447396
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in first-degree relatives of subjects with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Yetkin I; Ayvaz G; Cakir N; Arslan M
    Gynecol Endocrinol; 2005 Oct; 21(4):206-10. PubMed ID: 16316841
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The PPAR gamma 2 Pro12Ala variant predicts ESRD and mortality in patients with type 1 diabetes and diabetic nephropathy.
    Jorsal A; Tarnow L; Lajer M; Ek J; Hansen T; Pedersen O; Parving HH
    Mol Genet Metab; 2008 Jul; 94(3):347-51. PubMed ID: 18467141
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lack of association between the Pro12Ala polymorphism in PPAR-gamma2 gene and body weight changes, insulin resistance and chronic diabetic complications in obese patients with type 2 diabetes.
    Stefanski A; Majkowska L; Ciechanowicz A; Frankow M; Safranow K; Parczewski M; Pilarska K
    Arch Med Res; 2006 Aug; 37(6):736-43. PubMed ID: 16824933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Peroxisome proliferator activated receptor gamma Pro12Ala: old topic of conversation and new question].
    Fang FD
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2011 Dec; 33(6):591-2. PubMed ID: 22509537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.